Kinetic and Stoichiometric Modeling-Based Analysis of Docosahexaenoic Acid (DHA) Production Potential by Crypthecodinium cohnii from Glycerol, Glucose and Ethanol
Research output: Journal contributions › Journal articles › Research › peer-review
Standard
In: Marine Drugs, Vol. 20, No. 2, 115, 01.02.2022.
Research output: Journal contributions › Journal articles › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Kinetic and Stoichiometric Modeling-Based Analysis of Docosahexaenoic Acid (DHA) Production Potential by Crypthecodinium cohnii from Glycerol, Glucose and Ethanol
AU - Berzins, Kristaps
AU - Muiznieks, Reinis
AU - Baumanis, Matiss R.
AU - Strazdina, Inese
AU - Shvirksts, Karlis
AU - Prikule, Santa
AU - Galvanauskas, Vytautas
AU - Pleissner, Daniel
AU - Pentjuss, Agris
AU - Grube, Mara
AU - Kalnenieks, Uldis
AU - Stalidzans, Egils
N1 - This work was funded by the Latvian ERDF project 1.1.1.1/18/A/022. R.M., M.R.B. and A.P. were supported by University of Latvia under project “Climate change and its impacts on sustainability of natural resources” (Nr. Y5-AZ20-ZF-N-270).
PY - 2022/2/1
Y1 - 2022/2/1
N2 - Docosahexaenoic acid (DHA) is one of the most important long-chain polyunsaturated fatty acids (LC-PUFAs), with numerous health benefits. Crypthecodinium cohnii, a marine hetero-trophic dinoflagellate, is successfully used for the industrial production of DHA because it can ac-cumulate DHA at high concentrations within the cells. Glycerol is an interesting renewable substrate for DHA production since it is a by-product of biodiesel production and other industries, and is globally generated in large quantities. The DHA production potential from glycerol, ethanol and glucose is compared by combining fermentation experiments with the pathway-scale kinetic modeling and constraint-based stoichiometric modeling of C. cohnii metabolism. Glycerol has the slow-est biomass growth rate among the tested substrates. This is partially compensated by the highest PUFAs fraction, where DHA is dominant. Mathematical modeling reveals that glycerol has the best experimentally observed carbon transformation rate into biomass, reaching the closest values to the theoretical upper limit. In addition to our observations, the published experimental evidence indi-cates that crude glycerol is readily consumed by C. cohnii, making glycerol an attractive substrate for DHA production.
AB - Docosahexaenoic acid (DHA) is one of the most important long-chain polyunsaturated fatty acids (LC-PUFAs), with numerous health benefits. Crypthecodinium cohnii, a marine hetero-trophic dinoflagellate, is successfully used for the industrial production of DHA because it can ac-cumulate DHA at high concentrations within the cells. Glycerol is an interesting renewable substrate for DHA production since it is a by-product of biodiesel production and other industries, and is globally generated in large quantities. The DHA production potential from glycerol, ethanol and glucose is compared by combining fermentation experiments with the pathway-scale kinetic modeling and constraint-based stoichiometric modeling of C. cohnii metabolism. Glycerol has the slow-est biomass growth rate among the tested substrates. This is partially compensated by the highest PUFAs fraction, where DHA is dominant. Mathematical modeling reveals that glycerol has the best experimentally observed carbon transformation rate into biomass, reaching the closest values to the theoretical upper limit. In addition to our observations, the published experimental evidence indi-cates that crude glycerol is readily consumed by C. cohnii, making glycerol an attractive substrate for DHA production.
KW - Central metabolism
KW - Constraint-based model
KW - FTIR spectroscopy
KW - Kinetic model
KW - Krebs cycle
KW - Biology
UR - http://www.scopus.com/inward/record.url?scp=85123212193&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/486a38c4-538a-3cdb-a672-bcd7b1680e97/
U2 - 10.3390/md20020115
DO - 10.3390/md20020115
M3 - Journal articles
C2 - 35200644
AN - SCOPUS:85123212193
VL - 20
JO - Marine Drugs
JF - Marine Drugs
SN - 1660-3397
IS - 2
M1 - 115
ER -